Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2025 Aug 1.
Published in final edited form as: J Immunol. 2024 Aug 1;213(3):306–316. doi: 10.4049/jimmunol.2300890

Distinct localization, transcriptional profiles, and functionality in early life tonsil regulatory T cells

Shivali Verma *, Marissa C Bradley Ɨ, Joshua Gray *, Pranay Dogra *, Daniel P Caron *, Sarah Maurrasse ǂ, Eli Grunstein ǂ, Erik Waldman ǂ, Minyoung Jang ǂ, Kalpana Pethe Ɨ, Donna L Farber *,§, Thomas J Connors Ɨ
PMCID: PMC11304551  NIHMSID: NIHMS1999284  PMID: 38905110

Abstract

CD4+ regulatory T cells (Tregs) are key orchestrators of the immune system, fostering the establishment of protective immunity while preventing deleterious responses. Infancy and childhood are crucial periods of rapid immunologic development but how Tregs mediate immune responses at these earliest timepoints of human life is poorly understood. Here we compare blood and tissue (tonsil) Tregs across pediatric and adult subjects to investigate age related differences in Treg biology. We observed increased FoxP3 expression and proportions of Tregs in tonsil compared to paired blood samples in children. Within tonsil, early life Tregs accumulated in extrafollicular regions with cellular interactions biased towards CD8+ T cells. Tonsil Tregs in both children and adults expressed transcriptional profiles enriched for lineage defining signatures and canonical functionality compared to blood, suggesting tissue as the primary site of Treg activity. Early life tonsil Tregs transcriptional profiles were further defined by pathways associated with activation, proliferation, and polyfunctionality. Observed differences in pediatric tonsil Treg transcriptional signatures were associated with phenotypic differences, high proliferative capacity and robust production of IL-10 compared to adult Tregs. These results identify tissue as a major driver of Treg identity, provide new insights into developmental differences in Treg biology across the human lifespan and demonstrate unique functional properties of early life Tregs.

INTRODUCTION

The establishment of immunologic memory and self-tolerance are essential processes in immune system development. Infancy and childhood are critical timepoints for immune system development, establishment of immunologic memory and maturation of protective responses (1–3). The early life immune system is distinct from that in adults with unique functionality, transcriptional programming, and memory formation seen in T cells (4, 5). Immune responses during infancy can result in protection upon repeat antigenic exposure or give rise to aberrant responses which result in allergies and autoimmunity (6–8). Specialized cells within the immune system, particularly CD4+ regulatory T cells (Tregs), are responsible for limiting inflammation, establishing tolerance to environmental and self-antigens, maintaining tissue homeostasis, and directing responses to promote protective immunity (9–11). Understanding how immunity is trained and regulated at these earliest timepoints is critically important to our ability to improve immune health and harness these responses to advance disease outcomes across the human lifespan.

In mice, Tregs generated in the perinatal period are essential for preventing autoimmunity, exhibiting enhanced suppressive activity while expressing a transcriptome distinct from adult Tregs (12). In nonhuman primate newborn models, tissue localized Tregs displayed heightened upregulation of CD39 and reliance on T cell receptor (TCR) engagement for survival compared to adults (13). Studies using human cord blood, demonstrate increased utilization of CTLA-4 as an immunosuppressive mechanism and decreased ability to suppress dendritic cells (14, 15). Sequencing of cord blood Tregs reveals enrichment of canonical Treg genes suggesting that early life Tregs are primed for suppressive function (16). As these studies on Tregs rely on sampling of cord and peripheral blood they may not represent immune responses occurring in tissue environments, where the majority of immune responses occur (17).

Tregs have been identified in mucosal and lymphoid tissue sites throughout the human body (18). Within tissues, Tregs are known to have distinct roles which are tailored to the discrete environment (19, 20). Additionally, Tregs adopt tissue specific transcriptional signatures which translate to functional adaptations (21). Unfortunately, our understanding of how Tregs mediate immune responses within tissue during early life is incomplete due to difficulty accessing discrete tissue environments in infants and children. Due to their location in the oropharynx, the palatine tonsils are constantly exposed to aerosol and commensal antigens making them a site of significant immune activity. Tonsil Tregs have been found to prevent allergic responses, limit inflammation, and suppress germinal center reactions (22–24). As tonsils may be removed for elective purposes, they represent an opportunity to gain new insights into Treg biology within tissue.

In this study, we analyzed blood and tonsil Tregs obtained from pediatric and adult donors to reveal distinct properties of early life Tregs. Across these stages of life, Tregs are found in higher proportions and demonstrate increased expression of FoxP3 in tonsil compared to blood. Within the tonsil tissue architecture in children, Tregs accumulate in the extrafollicular space with biased interactions towards CD8+ T cells. Tonsillar Tregs are defined by a unique transcriptional signature compared to those found in circulation characterized by heightened expression of canonical regulatory pathways. Early life tonsil Tregs are further transcriptionally delineated by upregulation of genes associated with proliferation and polyfunctionality. Finally, we show that these differences result in an increased capacity for IL-10 production and proliferation following stimulation. Our results identify the tonsil as a unique tissue niche for Treg biology in early life and provide new insights into how early life Tregs are distinct from those in adults.

MATERIALS AND METHODS

Human samples

Human Subjects:

Pediatric subjects (n=88 aged 0–10; mean 3.5 years) less than 10 years of age, were recruited from the New York Presbyterian/Columbia University Irving Medical Center (NYP/CUIMC) Morgan Stanley Children’s Hospital outpatient surgery and pediatric clinics. After obtaining informed consent from parents/guardians, blood and/or tonsil tissue was collected from children undergoing phlebotomy for clinical purposes or elective tonsillectomy for obstructive sleep apnea. Adult subjects (n=4, aged 20–30 years) recruited from the CUIMC community provided blood samples for research purposes following informed consent. All human subjects work was performed under protocols approved by the Institutional Review Board of CUIMC.

Organ donors:

Tonsil tissue from deceased organ donors (n = 16, aged 20–50 years) were obtained at time of organ acquisition for clinical transplantation from donors whose consent for use of tissues for research was obtained by next-of kin through a long-standing protocol and material transfer agreement with LiveOnNY, the organ procurement organization for the New York metropolitan area, as previously described (3, 18, 25).

No subjects or donors included in this study had known immunodeficiency, chronic infection with Hepatitis B, C, or HIV, chronic tonsillitis, or evidence of an active infection.

Sample Processing

Blood:

Blood samples were spun down and plasma layer removed. Remaining non-plasma layer was diluted with EasySep buffer (PBS (Captivate Bio, cat PBS102) with 2% heat-inactivated fetal bovine serum (FBS, Thermo Fisher Cat #A3840101) and 1mM EDTA (Corning, Cat #46–034-CI)) and layered on top of Lymphocyte Separation Medium (Corning; Cat #25–072-CI) at a ratio of 1:3. Following centrifugation, buffy layer was isolated and diluted with EasySep buffer. Buffy layer was spun down and ACK Lysing Buffer (Gibco, cat A10492–01) added for 5 minutes to lyse red blood cells. Remaining human peripheral blood mononuclear cells were counted and single-cell suspension used as needed.

Tonsil:

Tissue sections were taken and fixed in Zinc Formalin Fixative for 48 hours then transferred to 70% EtOH. The remaining tissue was finely chopped, filtered through a 100-micron filter and spun down. ACK Lysing Buffer was added for 5 minutes to lyse red blood cells. The resultant single-cell suspensions were counted and then used for experiments or frozen.

Flow Cytometry and Cell Sorting

Flow Cytometry:

Single-cell suspensions were resuspended in PBS with a 1:1000 dilution of Fixable Viability Dye (Zombie NIR Biolegend Cat # 423105 or eFlour780 Thermo Fisher Cat #65-0865-14) for 30 min at 4°C. Cells were washed with FACS-buffer (PBS with 5% heat-inactivated FBS) then re-suspended in surface-stain antibody mix for 30 minutes at 4°C using a combination of the following antibodies: CD45-Alexa Flour 700 (Biolegend clone 2D1), CD3-BV650 (Biolegend clone OKT3), CD3-BUV395 (BD Biosciences clone UCHT1), CD4-PE/Cyanine7 (Biolegend clone RPA-T4), CD4-APCFire750 (Biolegend clone SK3), CD8-BV711 (Biolegend clone SK1), CD8-APC/Cyanine7 (Biolegend clone SK1), CD8-BUV805 (BD Biosciences clone SK1), CD25-FITC (Biolegend clone BC96), CD25-BUV564 (BD Biosciences clone M-A251), CD127-BV510 (Biolegend clone A019D5), CD127-APC (Biolegend clone A019D5), CCR2-PerCP/Cyanine5.5 (Biolegend clone K036C2), CCR4-APC (Biolegend cone L291H4), CCR5-BV750 (BD Biosciences clone 2D7), CCR9-PE (Biolegend clone L053E8), CD28-PE/Cyanine5 (BD Biosciences clone CD28.2), ICOS-BV711 (BD Biosciences clone DX29), CD11a-BV650 (BD Biosciences clone HI111). Cells were washed again with FACS-buffer and fixed with Fixation/Permeabilization Diluent (Invitrogen, ref 00-5223-56) and concentrate (Invitrogen, ref 00-5123-43) for 20 minutes at 4°C. Following fixation, cells were washed with FACS-buffer and intracellularly stained in Permeabilization Buffer 10X (Invitrogen, ref 00-833-56) and deionized water for 30 minutes at 4°C using a combination of the following antibodies: CTLA-4-PE/Cyanine5 (BD Biosciences clone BNI3), CTLA-4-BV605 (Biolegend clone BNI3), FoxP3-PE (Biolegend clone 206D), FoxP3-PE/Dazzle594 (Biolegend clone 206D), Ki67-AF647 (Biolegend clone Ki67). Cells were washed and re-suspended in FACS-buffer and flow cytometry data obtained on BD (Franklin Lakes, NJ) LSR II Flow Cytometer or Cytek (Fremont, CA) Aurora 5L instruments.

Cell sorting: immediately following surface staining cells were washed and re-suspended in EasySep buffer then desired CD4+ T cell populations (regulatory T cells (Tregs; CD25+/CD127−) and conventional CD4+ T cells (CD25−/CD127+/−) were sorted into FBS using a BD Influx cell sorter.

Whole transcriptome profiling by RNA sequencing

RNA Isolation:

Sorted cells were centrifuged and transferred to microcentrifuge tubes then centrifuged again. Pelleted cells were resuspended in 700μl of QIAzol lysis reagent (QIAGEN cat 79306) and vortexed. Lysed samples were homogenated in the TissueLyser LT (QIAGEN) for 5 minutes at 50Hz. Samples were rested for an additional 5 minutes then centrifuged through QIAshredder filters (QIAGEN cat 79656). Using the RNeasy plus micro kit (QIAGEN cat 74034) 100μl of gDNA eliminator solution and 140μl of chloroform was added followed by vortexing. Samples were then spun at 12,000g for 15 minutes at 4°C. RNA phase (top layer) was collected and transferred to new microcentrifuge tubes. An equivalent volume of 70% ethanol was added then transferred to an RNeasy MinElute spin column and washed with Buffer RWT and 2 rounds of Buffer RPE. Following a final wash of the column with 80% ethanol. RNA was eluted using RNase-Free water, run on an Agilent Bioanalyzer using the RNA 6000 Pico Kit (Agilent, cat 5067–1513) to assess RNA integrity then stored at −80°C.

RNA sequencing:

Library preparation and RNA sequencing was performed at the Columbia University Genome Center. Total RNA samples were submitted and enriched for mRNA using a poly-A pull down strategy. Single-end 100 base pair read sequencing at a depth of 30 million reads was performed on Illumina HiSeq 2500. Reads were aligned to the homo sapiens GRCh38 reference genome using kallisto (26). Differential gene expression analysis and principal component analysis was performed using DESeq2 (27).

Gene and Pathway Analysis

Gene Set Enrichment analysis (GSEA) was performed using GSEA v4.3.2 on differentially expressed gene (DEG) lists preranked by log fold change in normalized expression (28). Previously published gene ontology gene sets were accessed from the Molecular Signatures Database (29, 30). Additional gene ontology (GO) analysis was performed on DEG lists using PANTHER v17.0 overrepresentation test with Fisher’s exact test and GO database version 2022-07-01 (29, 31). Pathway analysis was performed on DEG lists via Enrichr, quantifying enrichment level of every pathway in the Kyoto Encyclopedia of Genes and Genomes (KEGG) 2021 human gene set (32–34). Pathway analysis figures were generated using the Enrichr Analysis Visualizer Appyter (35, 36).

T Cell Stimulation

Intracellular cytokine staining:

Sorted cells (see above) were stimulated with PMA (Sigma, Cat#P1585) (50ng/ML) and ionomycin (Sigma, Cat#I9657) (1μg/mL) in a 96-well U-bottom plate in an incubator for 6 hours in the presence of GolgiStop (BD Biosciences, cat#554724) and GolgiPlug (BD Bioscience cat#555029). Following stimulation, cells were centrifuged, fixed (as described above) then stained for intracellular cytokine detection using IL-10-PE (Biolegend clone JES3–927) with data obtained on BD LSR II Flow Cytometer.

Proliferation Assay:

Sorted Treg and conventional CD4+ cells were stained with CellTrace Yellow Dye (ThermoFisher cat C34573) then rested overnight in complete media (RPMI, (Corning Cat #10–040-CM) with 10% heat-inactivated FBS and 1% PSQ) in 96-well U-bottom plate in an incubator. Rested cells were stimulated the following day with ImmunoCult Human CD3/CD28 T Cell Activator (Stemcell, cat 10971) and left in culture for 72 hours then analyzed on BD LSR II Flow Cytometer.

Immunofluorescence Imaging

5μm sections were made into immunoblank slides and provided to the Human Immune Monitoring Core at CUIMC for immunofluorescence imaging. Sections were stained using the Opal 7-Color automated IHC detection kit (Akoya Biosciences) as previously described (37). The multiplex panel included DAPI, CD4 (clone EPR6855, Abcam), CD8 (clone 4B11, Leica), CD19 (clone BT51E, Leica), CD163 (clone 10D6, Leica), and FoxP3 (clone 236A/E7, Abcam). Images were acquired on the Vectra 3 platform and imported into QuPath – 0.3.0 (38) for analysis. Cell detection feature was used to define individual cell perimeters within the image. Single measurement classifier feature was used to classify markers and define cell subtypes; B cell, CD19+, Macrophage CD163+, CD8+ T cell, CD8+/CD4−/CD19−/CD163−, CD4+ conventional T cells, CD4+FoxP3−/CD8−/CD19−/CD163−, CD4+ Treg, CD4+FoxP3+/CD8−/CD19−/CD163−. Phenotypic classifications for each image were then exported for additional analysis.

Identification of follicles in human tonsils

We used the imcRtools package in R, a package commonly used to analyze imaging mass cytometry data (39, 40). X and Y coordinates of cells identified in each image were concatenated into a singleCellExperiment data container. All cells within a distance radius of 12.5μm were considered interacting using buildSpatialGraph with “expansion”. Using patchDetection function, spatial clusters of CD19+ cells were detected and defined as follicles if a minimum of 250 cells were in the patch. Non-CD19+ cells were included into follicles if they fell within 1μm of a CD19+ patch (expansion = 1). Cells outside these patches were classified as extrafollicular.

Measuring Treg interactions in the human tonsil

We measured the average number of interactions (by expansion) between Tregs and other cell types in the extrafollicular space using countInteractions in classic mode. To account for the differences in immune cell number and composition across images, we estimated randomly expected cell type interactions by randomizing the extrafollicular cellular labels within each image and recounting interactions for 100 iterations. We then compared the observed and randomly expected interactions to identify cell types with preferential colocalization or segregation. To visualize differences in interaction likelihood between children and adults, we divided observed interactions by randomly expected interactions.

Statistical Analysis

Flow cytometry: data were analyzed using FCS express (ver. 7.12.0005) and FlowJo (ver. 10.7.1). Descriptive analyses and statistical testing of compiled flow cytometry and imaging data were performed using Prism (GraphPad ver. 9.3.1).

Materials availability

This study did not generate new unique reagents.

Data and code availability

Population RNA sequencing data has been uploaded to GEO (GSE262622). Available at https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE262622

RESULTS

Tonsil tissue from pediatric subjects provides insight into early life regulatory T cells

We have previously acquired blood and/or tonsil tissue during pediatric ambulatory visits and elective surgical procedures to study immune system development (3, 41, 42). We obtained tonsil tissue and/or blood samples from pediatric (n= 88) subjects aged 0–10 years (see methods). Using flow cytometry, regulatory T cells (Tregs) were identified by cell surface marker expression (CD25+/CD127−) on CD4+ T cells along with intracellular detection of the canonical Treg transcription factor FoxP3 (Fig. 1A). In blood, the highest proportions of Tregs were noted in the first years of life whereas stable proportions were noted in tonsillar tissue (Fig. 1B). In paired tonsil and blood samples, proportions of Tregs and FoxP3 expression, as measured by mean fluorescence intensity, was highest in tonsil (Fig. 1C). The higher proportions and increased expression of FoxP3 seen in tonsil Tregs during childhood suggest tonsillar tissue is a unique tissue environment for investigating the role of Tregs in adaptive immunity.

Figure 1: Increased Treg proportions and FoxP3 expression in tonsil during early life.

Figure 1:

Flow cytometric assessment of Tregs in blood and tonsil. A) Gating strategy to identify Tregs; Live, CD45+, CD3+ cells were gated based on CD4 and CD8 expression. CD4+ cells which were CD127−/CD25hi and expressing FoxP3 were designated Tregs. B) Quantification of Tregs in blood (top; n = 65) and tonsil (bottom; n = 37) over age (years). Line depicts best fit linear regression with dotted lines representing 95% confidence interval. Shaded area represents normal ranges reported in adult blood (82). C) Paired pediatric tonsil and blood samples (n=22) by proportions of Tregs (top) and mean fluorescence intensity (MFI) of FoxP3 expression (bottom). Statistical testing with paired t-test. ** = p < 0.01, *** = p <0.001.

Tregs preferentially localize with extrafollicular CD8+ T cells during early life

As prior studies have shown differences in Treg proportions and phenotype in tissues when comparing infants to older children and adults (3, 18), we procured tonsils from adult organ donors (n=16) to define age related differences. We chose to compare our youngest subjects (< 3 years of age) to adults, eliminating the impact of ongoing early life immune development and maximizing age related differences in our analysis. We sought to define Treg localization to determine if spatial orientation differences existed. Multiplex immunofluorescent imaging was performed on tonsil tissue sections to identify immune cell subsets including conventional T cells (CD4+/FoxP3− or CD8+), Tregs (CD4+/FoxP3+), B cells (CD19+), and macrophages (CD163+) (Fig. 2A, Fig. S1A and methods). Using computational tissue segmentation analysis we identified follicular structures, enabling further categorization of immune cell subsets into discrete tissue areas; follicular vs extrafollicular (Fig. 2A, Fig. S1B and see methods). There were notable differences in cellular and tissue composition when comparing adult and pediatric tonsil. Pediatric tissues had increased overall cellular density, B cells, follicular area, and Tregs whereas adult tonsils had increased macrophages and CD8+ T cells (Fig. S1C). To determine if differences in tissue composition impacted Treg localization we analyzed Treg density by tissue structure. Despite pediatric samples having significantly increased follicular area, Treg density within follicles was similar to that in adults (Fig. 2B). Strikingly, Treg density was significantly higher in the extrafollicular space in pediatric tissue compared to adults (Fig. 2B).

Figure 2: Distinct spatial organization of pediatric Tregs in the extrafollicular space.

Figure 2:

Immunofluorescence imaging of Tregs in adult (n=3 subjects, 12 images; 2–7 images per donor) and pediatric (aged < 3 years; n =3 subjects, 14 images; 3–8 images per donor) tonsil tissue. A) Representative pediatric (left) and adult (right) tonsil stained with antibodies for DAPI, CD4, CD8, FoxP3, CD19, and CD163. Sections shown at 40x magnification and orange rectangle box shown as outset at 160x magnification. Green arrows and circles denote Tregs (CD4+/FoxP3+). B) Analysis of density of Tregs within follicle and extrafollicular regions (see methods). Bars represent mean with standard deviation. Statistical testing with one-way ANOVA. C) Analysis of spatial interactions of Treg and all other immune cells (B cell, Macrophage, CD4 conventional (Tconv), Treg, CD8). Box represents interquartile range with bars representing mean and range. Statistical testing with unpaired t-test. D) Analysis of mean Treg to individual immune cells in extrafollicular regions based on randomly expected vs observed interactions (see methods). Box represent interquartile range with bars representing mean and range. Statistical testing with unpaired or Mann-Whitney t-test. B-D) Individual subjects are denoted by distinct shapes.

**= p <0.01, *** = p<0.001.

The observed bias in tissue localization led us to investigate whether additional differences existed in interactions between Tregs and immune cell subsets. We quantified total Treg to cell interactions across the adult and pediatric groups and found no significant differences (Fig. 2C). We performed additional analysis on interactions occurring in the extrafollicular space given the observed bias of Treg density in early life (Fig. S1D and see methods). We found that adult Tregs mainly had observed interactions which were similar to what would be randomly expected, except for a decreased interaction with macrophages (Fig. S1D). In contrast, early life Tregs demonstrate decreased interactions with B cells and macrophages but increased interactions with conventional CD4+ and CD8+ T cells (Fig. S1D). Finally, we compared the Treg to cell interactions (observed divided by randomly expected) across age. While both adult and pediatric Tregs had been shown to have decreased interactions with macrophages, this difference was most apparent in adult tissue (Fig. 2D). Early life Treg interactions with B cells (decreased) and CD8+ T cells (increased) were both significantly different compared to adults (Fig. 2D). These observations were quite striking given the significantly reduced number of CD8+ T cells in pediatric tissue (Fig. S1C). Together these localization patterns reveal a bias of pediatric Tregs towards extrafollicular CD8+ T cells, suggesting a critical role for Tregs in shaping CD8+ T cell responses in early life.

Tissue location drives expression of regulatory T cell transcriptional signature

As circulating T cells enter tonsil tissue through high endothelial venules located in extrafollicular zones (43), we hypothesized that blood Tregs could be contributing to the increased frequency of extrafollicular Tregs in children (Fig. 2B). To assess similarity between circulating and tonsil Tregs we recruited healthy adult blood donors (n=4) and performed population RNA sequencing on sorted blood and tonsil conventional CD4+ CD25−/CD127+/− T cells (TConv) and Tregs from pediatric (n= 8, aged < 3 years) and adult (n=7) donors/subjects (see methods, Fig. 1A). Principal component analysis (PCA) demonstrated that tissue location and cell subset were the major drivers of variance (Fig. S2A) with canonical Treg (FOXP3 and IL2RA) and conventional (IL7R and THEMIS) genes differentially expressed between the subsets (Fig. S2B/C). Analysis of the top 50 DEGs revealed enrichment of genes associated with Treg identity, including, BATF (44, 45), IKZF4 (46, 47), TNFRSF9 (48), TNFRSF18 (49), LRRC32 (50), LAYN and RTNK2 (51) (Fig. S2C) demonstrating that our sorting strategy resulted in isolation of targeted subsets. Relative expression of individual genes within the DEG analysis suggested additional differences within the Treg population were likely to exist based on age and tissue site.

To identify whether Tregs derived from blood and tonsillar tissue of adult and pediatric donors exhibited differentiated identities, we directly compared their gene expression profiles. PCA performed on all Tregs revealed tissue location as the main driver of transcriptional variance, with donor age related differences visible to an extent in blood, but markedly apparent within tonsillar Tregs (Fig. 3A). DEG analysis similarly demonstrated that gene expression patterns segregate primarily by tissue source (Fig. 3B). Notably, compared to circulating Tregs, tonsillar Tregs exhibit upregulation of key genes involved in Treg immunosuppressive activity such as IL10 and LAG3 (52, 53). To further characterize this tonsil-specific signature, we performed independent analyses comparing tonsillar to circulating Tregs within the two separate age cohorts. We found a considerable degree of overlap between their DEG lists (697 genes) with 923 and 1562 genes differentially expressed in only the pediatric or adult cohorts respectively (Fig. 3C). The set of 697 shared genes representing a conserved tonsil Treg signature was analyzed via GSEA to infer age-independent tissue Treg specialization and was found to be enriched for multiple functional processes including regulation of T cell activation (GO:0050863), regulation of interleukin-10 production (GO:0032733), and regulation of T cell cytokine production (GO:0002724) (Fig. 3D and Table S1). These results support tissue as a distinct location of Treg activity throughout human life and suggest that within tissue, Tregs adapt to the unique challenges posed by discrete phases of human life.

Figure 3: Tissue drives differences in transcriptional signature of Tregs.

Figure 3:

Whole transcriptome profiling by RNA sequencing of sorted blood and tonsil Tregs. A) Principal component (PC) analysis of samples from tonsil (triangles) and blood (circles) from adult (purple; n = 7) and pediatric (aged <3 years, green; n = 8) subjects. Large circles represent one standard deviation based on combined group (site + age). B) Heatmap depicting row normalized gene expression of top 40 differentially expressed genes (DEG) between blood (orange) and tonsil (blue) Tregs. C) Venn diagram of DEGs when comparing tonsil to blood Treg within age cohort with overlap representing shared DEGs; adult subjects (purple) or pediatric subjects (green). D) Representative gene set enrichment analysis pathway based on shared tonsil DEGs. GO = gene ontology.

Increased functional signature defines early life tonsillar regulatory T cells

As the majority of immune responses occur within tissue and notable differences were observed across age in tonsil Treg localization and transcriptional signatures, we performed additional analysis on tonsil Tregs. DEG between pediatric and adults tonsillar Tregs were identified and used to perform pathway analysis (see methods, Fig. 4A, and Table S2). In the pediatric group, a dramatic increase in pathways indicating cellular turnover was noted, as demonstrated by the nearly tenfold overrepresentation of Cell Cycle (MAP04110) and DNA Replication (MAP03030) pathways. In addition, pathways for expression of Cell Adhesion genes (MAP04514), phosphatidylinositol 3-kinase (PI3K)-Akt signaling (MAP04151) and TNF signaling (MAP04668) were also preferentially upregulated, indicating subtler tuning of tonsillar Treg function and phenotype in early life. Fewer pathways were significantly upregulated in adult tonsil Tregs compared to children, and included Calcium Signaling Pathway (MAP04020), MAPK signaling pathway (MAP04010), and Cytokine-Cytokine receptor interaction (MAP04060) (Table S2). To further explore differences related to Treg biology we removed genes appearing in the Gene Ontology Biologic Process “Cell_Cycle_Process” gene set (GO 0022402) and repeated GSEA on the remaining 1,061 DEG (549 pediatric, 512 adult). Pediatric Tregs were enriched for Negative Regulation of Immune System Process (GO 002683) and Regulation of Lymphocyte Activation (GO 0050870) (Fig. 4B) suggesting a potentially enhanced effector identity in early life.

Figure 4: Distinct pathway and gene signatures in pediatric tonsil Tregs.

Figure 4:

Analysis of Treg transcriptional signatures across age within tonsil. A) Pathway analysis graph showing enrichment level of every KEGG 2021 human pathway in the list of differentially expressed genes upregulated in pediatric (aged < 3 years, n = 4) compared to adult (n = 3) tonsil Tregs by −log10 p value vs odds ratio. B) Representative gene set enrichment analysis based on differentially expressed genes in pediatric vs adult tonsil Tregs after removal of cell cycle genes. C) Heatmap depicting row normalized expression of selected Treg genes comparing adult (purple) and pediatric (green) cohorts. * = p<0.05 and log2 fold change >1. NES = normalized enrichment score. GO = gene ontology

Transcriptionally, Tregs can be defined by a set of genes associated with their identity, including FOXP3, CTLA4, and others. We selected a gene set defining an effector Treg gene signature (54, 55) and summarized core gene expression (Fig. 4C). The 39 core gene set was separated into 2 major nodes. The first node contained 22 genes of which 13 demonstrated increased expression in pediatric tonsillar Tregs. These included genes for costimulatory molecules CTLA4, ICOS, and LAG3, known to correlate with stronger immunosuppressive capabilities in Tregs (56–58) and activation of PI3K-Akt signaling (59). The pediatric Treg group displayed increased expression of CCR5, key for suppression of CD8+ T cell responses (60), and IL10, coding for the anti-inflammatory cytokine characteristically produced by Tregs (61). The second node of 17 genes included lineage defining genes FOXP3 and IL2RA (Fig. 4C), which were not differentially expressed. Only 2 DEGs emerged from this set including, LGALS1, which functions in cell adhesion, and UTS2, recently identified as part of a human Treg core gene set (51), with both being increased in adults. Altogether these discrete differences in early life Tregs reveal preferentially activated pathways associated with Treg suppressive functionality, distinguishing themselves from their adult counterparts.

Phenotype of early life and adult tonsillar Tregs follow transcriptomic distinctions

To validate protein expression of key DEG across age cohorts, we performed flow-cytometric phenotyping on pediatric and adult tonsil Tregs. Overall, differences in the phenotype of both groups closely followed their transcriptomic signatures. Consistent with the prominent expression of cell cycle genes (Fig. 4A) pediatric Tregs expressed high levels of Ki67+ (Fig. 5A). Early life Tregs were further characterized by significantly increased expression of costimulatory molecules ICOS, which results in signaling through the PI3K pathway (Fig. 4A), and CD28 (Fig. 5B). While CTLA4 was differentially expressed at the transcript level, proportions of CTLA-4+ Tregs did not differ (data not shown) and increased mean fluorescence intensity in the pediatric Tregs did not reach statistical significance (Fig. 5C). The transcription factor Helios, encoded by IKZF2, which is a marker of Treg stability in humans (62, 63) was also similar between groups (Fig. 5D). To examine if differential adaptations to the tissue environment were present, we assessed expression of ligand CD11a, encoded by IGTAL, and CD69, an activation and canonical tissue residency marker, which both showed similar expression across age (Fig. 5E). Similar proportions of CD39 (encoded by ENTPD1) were also observed, consistent with its variable expression across age cohorts (Fig. 4C and 5F). As homing receptor CCR5 was among the DEGs (Fig. 4C) we assessed the expression of several chemokine receptors. CCR5 and CCR2, known to promote Treg abundance in secondary lymphoid organs by enhancing CD25 expression (64) were increased in pediatric Tregs whereas CCR4 was found to be higher in adult Tregs (Fig. 5G). These data demonstrate that transcriptional signatures largely translated to protein expression with differential adaptations existing across age.

Figure 5: Differential Treg transcriptional signatures translate to distinct phenotypic characteristics.

Figure 5:

Flow cytometric analysis of tonsil Tregs from adults (squares; n=4–8) and pediatric (aged <3 years, circles; n=5–10) subjects. A) Compiled data for Ki67 expression. B) Compiled data for co-stimulatory molecule expression. C) Compiled data for mean fluorescence intensity (MFI) of CTLA-4. D) Complied data for transcription factor Helios expression. E) Compiled data for CD69 and CD11a expression. F) Compiled data for CD39 expression. G) Compiled data for chemokine receptor expression. For all data bars depict mean with standard deviation. Statistical testing with Mann-Whitney t-test. * = p <0.05, ** = p<0.01.

Enhanced functionality defines early life regulatory T cells

Our RNA sequencing analysis revealed DEGs associated with Treg effector function including IL10 and GZMB (Fig. 4C) and upregulated pathways related to cell cycle. We sought to determine if early life Tregs possessed differential functional ability. Tonsil Tregs were sorted (Fig. 1A and see methods) then stimulated and stained for intracellular cytokine detection using flow cytometry. Pediatric Tregs produced significantly more IL-10 compared to adults (Fig. 6A), suggesting an increased ability to produce canonical Treg cytokines. To determine if differences in proliferative ability existed, we performed a proliferation assay on sorted Treg and conventional CD4+ T cells (see methods and Fig. 6B). Pediatric Tregs had both a higher division index and proliferation index, which excludes cells that never divided, compared to adult Tregs (Fig. 6C). As other early life T cell subsets are known to undergo increased proliferation following stimulation (65) this ability may be a unique property of early life that is lost with aging. These results reveal an enhanced ability to perform canonical effector cytokine function and capabilities not present in later life.

Figure 6: Early life tonsil Tregs display enhanced and distinct functionality.

Figure 6:

Comparison of adult and pediatric (aged <3 years) tonsil Treg cytokine production and proliferation ability. A) Intracellular cytokine staining by flow cytometry for IL-10 following PMA/ION stimulation with representative (left) and compiled data (right). Bars represent mean with standard deviation. Statistical testing with Mann-Whitney t-test. B) Representative proliferation flow data of pediatric (left) and adult (right) Treg and conventional CD4+ T cells (Tconv) at 72 hours following CD3/CD28 stimulation (top) with proliferation fit modeling (bottom). Vertical green line denotes undivided cells with red line outlining total population and green lines under curve denoting fitted divisions. C) Compiled data from proliferation assay with division index (left) and proliferation index (right); adults n = 6, pediatric n = 7. Lines depict mean with standard deviation. Statistical testing with one-way ANOVA. * = p<0.05, ** = p <0.01.

DISCUSSION

This study provides an in-depth analysis of Tregs in early human life across blood and tonsil compartments, identifying unique properties of pediatric tonsil Tregs. Within the structure of the tissue environment early life Tregs accumulate in the extrafollicular space clustering with conventional T cells, particularly CD8+ T cells. Our analyses demonstrate that tissue is the major driver of Treg transcriptional signatures with a conserved tissue signature shared between pediatric and adult tonsil Tregs. This shared signature reveals regulation of T cell activity as a fundamental feature of tissue Tregs. During early life, Tregs exhibit high levels of turnover with increased expression of genes associated with canonical Treg functionality. These differences translate into increased ability to produce IL-10 and a distinct capacity to proliferate following stimulation. This study provides new insights into the unique spatial, transcriptional, phenotypic, and functional identity of early life Tregs.

Lymphoid tissues are critical sites for germinal center reactions, antibody production, and T cell differentiation. Within lymph nodes and lymphoid tissues, naïve T cells circulate experiencing frequent interactions with antigen presenting cells (66) and upon recognition of their cognate antigen, can differentiate into effector and memory subsets (66–68). Tregs positioned within lymphoid structures are essential for recognition of self-antigens (69) and suppression of self-reactive T cells (70). Within the tonsil, higher proportions of Tregs can be attributed to increased density within the extrafollicular space, which is dominated by T cell and antigen presenting cell interactions (67). Denser proportions of Tregs within close proximity to highly proliferative early life T cells is likely to be beneficial to the establishment of productive memory by exerting tighter control over this dynamic process. The development of asthma, atopic dermatitis, type 1 diabetes and allergies have been associated with the propagation of aberrant and auto-reactive T cell responses (71–73), highlighting the critical role for Tregs in controlling T cell immunity. As memory is established and adapts to the tissue niche some Treg roles are performed by resident memory T cells (74), which may explain the decreased proportions of Tregs in tissue seen with age (3, 18). Further exploration of developmental processes is needed to fully delineate how immune cell subset roles evolve over human life.

The myriad of antigenic challenges of early life necessitates a program of immune regulation which is highly reliable. Tregs are central to this process as evidenced by the levels of autoimmunity which occur when they are defective (75). One mechanism by which Tregs orchestrate immune responses is through ICOS signaling. ICOS is a costimulatory molecule which promotes T cell proliferation and cytokine production (76). In Tregs ICOS expression is associated with increased IL-10 production, proliferation, and immunosuppressive ability (59, 77). Interestingly, ICOS signaling results in stimulation of the PI3K pathway which can result in promotion of FoxP3 expression or loss of Treg identity if not tightly regulated (78). Regulation of ICOS expression can be further controlled by the transcription factor JunB which promotes Treg homeostasis and effector functioning (79). Strikingly, loss of ICOS+ Tregs in the neonatal non obese mouse model for type 1 diabetes results in progression of disease supporting the critical role of this pathway in early life (80). Early life tonsil Tregs differentially express the genes ICOS and JUNB, which translates to increased surface expression of ICOS, robust IL-10 production, and high proliferative capacity. This suggests that ICOS mediated immune suppression could be a defining feature of pediatric Tregs and a potential targetable pathway for immunotherapy.

The identification of distinct localization and functionality of early life Tregs has several important implications. Understanding the normal developmental processes of key immune cell subsets facilitates identification of aberrancies within discrete disease processes. This is of particular importance in infancy and childhood where many atopic diseases, like food allergies, asthma and type 1 diabetes, first manifest. Infancy and childhood are also key timepoints for the establishment of protective responses to pathogens through vaccination or primary infection. Appreciating differences in how these responses are generated is key to the creation of developmentally appropriate prevention and treatment modalities. Importantly, heterogeneity within the Treg lineage enabling both context and tissue specific responses exist (21). Follicular Tregs which perform critical functions within lymphoid tissues are an example of this specialization but have been found to downregulate CD25 (81) and their contribution to differences across age may be underappreciated in this study. Future studies dissecting differences in Treg heterogeneity across age would significantly improve our ability to harness unique properties of Tregs derived in early life and open new therapeutic options in the fields of autoimmunity, cancer, and transplantation.

In summary our results reveal unique properties of early life tissue Tregs which play a critical role in the establishment of protective immune responses and prevention of autoimmunity.

Supplementary Material

1

Key Points.

Location within tissue drives expression of Treg identity

Biased Treg to CD8+ T cell interactions occur in extrafollicular space in children

Distinct transcription and functional properties define pediatric Tregs

ACKNOWLEDGEMENTS

We thank the subjects and families who participated in this study. We extend our gratitude to the families whose gift of organ donation made this work possible and the transplant coordinators of LiveOnNY. We thank Carlos Aguilar-Breton for human subject enrollment. We thank Filip Cvetkovski for help with RNA extraction.

Grant Support

This work was supported by the US National Institutes of Health (NIH) (grant nos. K23AI141686 (TJC), U01AI100119, and P01AI106697 (DLF). Research reported here was performed in the Columbia Flow Cytometry Core (supported by NIH awards S10RR027050, S10OD030282, and S10OD020056) and used resources of the Human Immune Monitoring Core at Columbia University. Additional support was provided in part by Columbia University’s CTSA grant no. UL1TR001873 from NCATS/NIH. The content is solely the responsibility of the authors and does not necessarily represent official views of the NIH.

Abbreviations

CUIMC

Columbia University Irving Medical Center

DEG

differentially expressed gene

GO

gene ontology

GSEA

Gene set enrichment analysis

PCA

principal component analysis

NYP

New York Presbyterian

TConv

conventional T cell

TCR

T cell receptor

Tregs

regulatory T cells

Footnotes

Declaration of Interests

The authors declare no competing interests.

REFERENCES

  • 1.Olin A, Acevedo N, Lakshmikanth T, Chen Y, Johansson C, Alm J, Scheynius A, and Brodin P. 2022. Longitudinal analyses of development of the immune system during the first five years of life in relation to lifestyle. Allergy 77: 1583–1595. [DOI] [PubMed] [Google Scholar]
  • 2.Olin A, Henckel E, Chen Y, Lakshmikanth T, Pou C, Mikes J, Gustafsson A, Bernhardsson AK, Zhang C, Bohlin K, and Brodin P. 2018. Stereotypic Immune System Development in Newborn Children. Cell 174: 1277–1292 e1214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Connors TJ, Matsumoto R, Verma S, Szabo PA, Guyer R, Gray J, Wang Z, Thapa P, Dogra P, Poon MML, Rybkina K, Bradley MC, Idzikowski E, McNichols J, Kubota M, Pethe K, Shen Y, Atkinson MA, Brusko M, Brusko TM, Yates AJ, Sims PA, and Farber DL. 2023. Site-specific development and progressive maturation of human tissue-resident memory T cells over infancy and childhood. Immunity. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Gibbons D, Fleming P, Virasami A, Michel ML, Sebire NJ, Costeloe K, Carr R, Klein N, and Hayday A. 2014. Interleukin-8 (CXCL8) production is a signatory T cell effector function of human newborn infants. Nat Med 20: 1206–1210. [DOI] [PubMed] [Google Scholar]
  • 5.Zens KD, Chen JK, Guyer RS, Wu FL, Cvetkovski F, Miron M, and Farber DL. 2017. Reduced generation of lung tissue-resident memory T cells during infancy. J Exp Med 214: 2915–2932. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Lambrecht BN, and Hammad H. 2017. The immunology of the allergy epidemic and the hygiene hypothesis. Nat Immunol 18: 1076–1083. [DOI] [PubMed] [Google Scholar]
  • 7.Murrison LB, Brandt EB, Myers JB, and Hershey GKK. 2019. Environmental exposures and mechanisms in allergy and asthma development. J Clin Invest 129: 1504–1515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Renz H, and Skevaki C. 2021. Early life microbial exposures and allergy risks: opportunities for prevention. Nat Rev Immunol 21: 177–191. [DOI] [PubMed] [Google Scholar]
  • 9.Sakaguchi S, Yamaguchi T, Nomura T, and Ono M. 2008. Regulatory T cells and immune tolerance. Cell 133: 775–787. [DOI] [PubMed] [Google Scholar]
  • 10.Campbell C, and Rudensky A. 2020. Roles of Regulatory T Cells in Tissue Pathophysiology and Metabolism. Cell Metab 31: 18–25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Sharma A, and Rudra D. 2018. Emerging Functions of Regulatory T Cells in Tissue Homeostasis. Front Immunol 9: 883. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Yang S, Fujikado N, Kolodin D, Benoist C, and Mathis D. 2015. Immune tolerance. Regulatory T cells generated early in life play a distinct role in maintaining self-tolerance. Science 348: 589–594. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Holbrook BC, and Alexander-Miller MA. 2020. Higher Frequency and Increased Expression of Molecules Associated with Suppression on T Regulatory Cells from Newborn Compared with Adult Nonhuman Primates. J Immunol 205: 2128–2136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Rueda CM, Moreno-Fernandez ME, Jackson CM, Kallapur SG, Jobe AH, and Chougnet CA. 2015. Neonatal regulatory T cells have reduced capacity to suppress dendritic cell function. Eur J Immunol 45: 2582–2592. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Hayakawa S, Ohno N, Okada S, and Kobayashi M. 2017. Significant augmentation of regulatory T cell numbers occurs during the early neonatal period. Clin Exp Immunol 190: 268–279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Motwani K, Peters LD, Vliegen WH, El-Sayed AG, Seay HR, Lopez MC, Baker HV, Posgai AL, Brusko MA, Perry DJ, Bacher R, Larkin J, Haller MJ, and Brusko TM. 2020. Human Regulatory T Cells From Umbilical Cord Blood Display Increased Repertoire Diversity and Lineage Stability Relative to Adult Peripheral Blood. Front Immunol 11: 611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Farber DL 2021. Tissues, not blood, are where immune cells function. Nature 593: 506–509. [DOI] [PubMed] [Google Scholar]
  • 18.Thome JJ, Bickham KL, Ohmura Y, Kubota M, Matsuoka N, Gordon C, Granot T, Griesemer A, Lerner H, Kato T, and Farber DL. 2016. Early-life compartmentalization of human T cell differentiation and regulatory function in mucosal and lymphoid tissues. Nat Med 22: 72–77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Munoz-Rojas AR, and Mathis D. 2021. Tissue regulatory T cells: regulatory chameleons. Nat Rev Immunol 21: 597–611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Feuerer M, Hill JA, Mathis D, and Benoist C. 2009. Foxp3+ regulatory T cells: differentiation, specification, subphenotypes. Nat Immunol 10: 689–695. [DOI] [PubMed] [Google Scholar]
  • 21.Miragaia RJ, Gomes T, Chomka A, Jardine L, Riedel A, Hegazy AN, Whibley N, Tucci A, Chen X, Lindeman I, Emerton G, Krausgruber T, Shields J, Haniffa M, Powrie F, and Teichmann SA. 2019. Single-Cell Transcriptomics of Regulatory T Cells Reveals Trajectories of Tissue Adaptation. Immunity 50: 493–504 e497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Lim HW, Hillsamer P, and Kim CH. 2004. Regulatory T cells can migrate to follicles upon T cell activation and suppress GC-Th cells and GC-Th cell-driven B cell responses. J Clin Invest 114: 1640–1649. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Hewavisenti RV, Ferguson AL, Gasparini G, Ohashi T, Braun A, Watkins TS, Miles JJ, Elliott M, Sierro F, Feng CG, Britton WJ, Gebhardt T, Tangye S, and Palendira U. 2021. Tissue-resident regulatory T cells accumulate at human barrier lymphoid organs. Immunol Cell Biol 99: 894–906. [DOI] [PubMed] [Google Scholar]
  • 24.Palomares O, Ruckert B, Jartti T, Kucuksezer UC, Puhakka T, Gomez E, Fahrner HB, Speiser A, Jung A, Kwok WW, Kalogjera L, Akdis M, and Akdis CA. 2012. Induction and maintenance of allergen-specific FOXP3+ Treg cells in human tonsils as potential first-line organs of oral tolerance. J Allergy Clin Immunol 129: 510–520, 520 e511–519. [DOI] [PubMed] [Google Scholar]
  • 25.Carpenter DJ, Granot T, Matsuoka N, Senda T, Kumar BV, Thome JJC, Gordon CL, Miron M, Weiner J, Connors T, Lerner H, Friedman A, Kato T, Griesemer AD, and Farber DL. 2018. Human immunology studies using organ donors: Impact of clinical variations on immune parameters in tissues and circulation. Am J Transplant 18: 74–88. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Bray NL, Pimentel H, Melsted P, and Pachter L. 2016. Near-optimal probabilistic RNA-seq quantification. Nat Biotechnol 34: 525–527. [DOI] [PubMed] [Google Scholar]
  • 27.Love MI, Huber W, and Anders S. 2014. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15: 550. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, and Mesirov JP. 2005. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545–15550. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, and Sherlock G. 2000. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25: 25–29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Gene Ontology, C., Aleksander SA, Balhoff J, Carbon S, Cherry JM, Drabkin HJ, Ebert D, Feuermann M, Gaudet P, Harris NL, Hill DP, Lee R, Mi H, Moxon S, Mungall CJ, Muruganugan A, Mushayahama T, Sternberg PW, Thomas PD, Van Auken K, Ramsey J, Siegele DA, Chisholm RL, Fey P, Aspromonte MC, Nugnes MV, Quaglia F, Tosatto S, Giglio M, Nadendla S, Antonazzo G, Attrill H, Dos Santos G, Marygold S, Strelets V, Tabone CJ, Thurmond J, Zhou P, Ahmed SH, Asanitthong P, Luna Buitrago D, Erdol MN, Gage MC, Ali Kadhum M, Li KYC, Long M, Michalak A, Pesala A, Pritazahra A, Saverimuttu SCC, Su R, Thurlow KE, Lovering RC, Logie C, Oliferenko S, Blake J, Christie K, Corbani L, Dolan ME, Drabkin HJ, Hill DP, Ni L, Sitnikov D, Smith C, Cuzick A, Seager J, Cooper L, Elser J, Jaiswal P, Gupta P, Jaiswal P, Naithani S, Lera-Ramirez M, Rutherford K, Wood V, De Pons JL, Dwinell MR, Hayman GT, Kaldunski ML, Kwitek AE, Laulederkind SJF, Tutaj MA, Vedi M, Wang SJ, D’Eustachio P, Aimo L, Axelsen K, Bridge A, Hyka-Nouspikel N, Morgat A, Aleksander SA, Cherry JM, Engel SR, Karra K, Miyasato SR, Nash RS, Skrzypek MS, Weng S, Wong ED, Bakker E, Berardini TZ, Reiser L, Auchincloss A, Axelsen K, Argoud-Puy G, Blatter MC, Boutet E, Breuza L, Bridge A, Casals-Casas C, Coudert E, Estreicher A, Livia Famiglietti M, Feuermann M, Gos A, Gruaz-Gumowski N, Hulo C, Hyka-Nouspikel N, Jungo F, Le Mercier P, Lieberherr D, Masson P, Morgat A, Pedruzzi I, Pourcel L, Poux S, Rivoire C, Sundaram S, Bateman A, Bowler-Barnett E, Bye AJH, Denny P, Ignatchenko A, Ishtiaq R, Lock A, Lussi Y, Magrane M, Martin MJ, Orchard S, Raposo P, Speretta E, Tyagi N, Warner K, Zaru R, Diehl AD, Lee R, Chan J, Diamantakis S, Raciti D, Zarowiecki M, Fisher M, James-Zorn C, Ponferrada V, Zorn A, Ramachandran S, Ruzicka L, and Westerfield M. 2023. The Gene Ontology knowledgebase in 2023. Genetics 224. [Google Scholar]
  • 31.Thomas PD, Ebert D, Muruganujan A, Mushayahama T, Albou LP, and Mi H. 2022. PANTHER: Making genome-scale phylogenetics accessible to all. Protein Sci 31: 8–22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Chen EY, Tan CM, Kou Y, Duan Q, Wang Z, Meirelles GV, Clark NR, and Ma’ayan A. 2013. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics 14: 128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Kuleshov MV, Jones MR, Rouillard AD, Fernandez NF, Duan Q, Wang Z, Koplev S, Jenkins SL, Jagodnik KM, Lachmann A, McDermott MG, Monteiro CD, Gundersen GW, and Ma’ayan A. 2016. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res 44: W90–97. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Carbon S, Mungall C 2018. Gene Ontology Data Archive. Zenodo, ed. [Google Scholar]
  • 35.Kanehisa M, and Goto S. 2000. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28: 27–30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Xie Z, Bailey A, Kuleshov MV, Clarke DJB, Evangelista JE, Jenkins SL, Lachmann A, Wojciechowicz ML, Kropiwnicki E, Jagodnik KM, Jeon M, and Ma’ayan A. 2021. Gene Set Knowledge Discovery with Enrichr. Curr Protoc 1: e90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Chait M, Yilmaz MM, Shakil S, Ku AW, Dogra P, Connors TJ, Szabo PA, Gray JI, Wells SB, Kubota M, Matsumoto R, Poon MM, Snyder ME, Baldwin MR, Sims PA, Saqi A, Farber DL, and Weisberg SP. 2022. Immune and epithelial determinants of age-related risk and alveolar injury in fatal COVID-19. JCI Insight 7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Bankhead P, Loughrey MB, Fernandez JA, Dombrowski Y, McArt DG, Dunne PD, McQuaid S, Gray RT, Murray LJ, Coleman HG, James JA, Salto-Tellez M, and Hamilton PW. 2017. QuPath: Open source software for digital pathology image analysis. Sci Rep 7: 16878. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Windhager J, Zanotelli VRT, Schulz D, Meyer L, Daniel M, Bodenmiller B, and Eling N. 2023. An end-to-end workflow for multiplexed image processing and analysis. Nat. Protoc 18: 3565–3613. [DOI] [PubMed] [Google Scholar]
  • 40.Hoch T, Schulz D, Eling N, Gomez JM, Levesque MP, and Bodenmiller B. 2022. Multiplexed imaging mass cytometry of the chemokine milieus in melanoma characterizes features of the response to immunotherapy. Sci Immunol 7: eabk1692. [DOI] [PubMed] [Google Scholar]
  • 41.Hegewisch-Solloa E, Seo S, Mundy-Bosse BL, Mishra A, Waldman EH, Maurrasse S, Grunstein E, Connors TJ, Freud AG, and Mace EM. 2021. Differential Integrin Adhesome Expression Defines Human NK Cell Residency and Developmental Stage. J Immunol 207: 950–965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Rybkina K, Bell JN, Bradley MC, Wohlbold T, Scafuro M, Meng W, Korenberg RC, Davis-Porada J, Anderson BR, Weller RJ, Milner JD, Moscona A, Porotto M, Luning Prak ET, Pethe K, Connors TJ, and Farber DL. 2023. SARS-CoV-2 infection and recovery in children: Distinct T cell responses in MIS-C compared to COVID-19. J Exp Med 220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Brandtzaeg P 2015. Immunobiology of Tonsils and Adenoids. In Mucosal Immunology, 4th ed. Jiri Mestecky WS, Russell Michael W., Kelsall Brian L., Cheroutre Hilde, Lambrecht Bart N., ed. Academic Press. 1985–2016. [Google Scholar]
  • 44.Xu C, Fu Y, Liu S, Trittipo J, Lu X, Qi R, Du H, Yan C, Zhang C, Wan J, Kaplan MH, and Yang K. 2021. BATF Regulates T Regulatory Cell Functional Specification and Fitness of Triglyceride Metabolism in Restraining Allergic Responses. J Immunol 206: 2088–2100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Trujillo-Ochoa JL, Kazemian M, and Afzali B. 2023. The role of transcription factors in shaping regulatory T cell identity. Nat Rev Immunol. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Morikawa H, and Sakaguchi S. 2014. Genetic and epigenetic basis of Treg cell development and function: from a FoxP3-centered view to an epigenome-defined view of natural Treg cells. Immunol Rev 259: 192–205. [DOI] [PubMed] [Google Scholar]
  • 47.Pan F, Yu H, Dang EV, Barbi J, Pan X, Grosso JF, Jinasena D, Sharma SM, McCadden EM, Getnet D, Drake CG, Liu JO, Ostrowski MC, and Pardoll DM. 2009. Eos mediates Foxp3-dependent gene silencing in CD4+ regulatory T cells. Science 325: 1142–1146. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Marson A, Kretschmer K, Frampton GM, Jacobsen ES, Polansky JK, MacIsaac KD, Levine SS, Fraenkel E, von Boehmer H, and Young RA. 2007. Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature 445: 931–935. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Mahmud SA, Manlove LS, Schmitz HM, Xing Y, Wang Y, Owen DL, Schenkel JM, Boomer JS, Green JM, Yagita H, Chi H, Hogquist KA, and Farrar MA. 2014. Costimulation via the tumor-necrosis factor receptor superfamily couples TCR signal strength to the thymic differentiation of regulatory T cells. Nat Immunol 15: 473–481. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Tran DQ, Andersson J, Wang R, Ramsey H, Unutmaz D, and Shevach EM. 2009. GARP (LRRC32) is essential for the surface expression of latent TGF-beta on platelets and activated FOXP3+ regulatory T cells. Proc Natl Acad Sci U S A 106: 13445–13450. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Bhairavabhotla R, Kim YC, Glass DD, Escobar TM, Patel MC, Zahr R, Nguyen CK, Kilaru GK, Muljo SA, and Shevach EM. 2016. Transcriptome profiling of human FoxP3+ regulatory T cells. Hum Immunol 77: 201–213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Huang CT, Workman CJ, Flies D, Pan X, Marson AL, Zhou G, Hipkiss EL, Ravi S, Kowalski J, Levitsky HI, Powell JD, Pardoll DM, Drake CG, and Vignali DA. 2004. Role of LAG-3 in regulatory T cells. Immunity 21: 503–513. [DOI] [PubMed] [Google Scholar]
  • 53.Fujio K, Yamamoto K, and Okamura T. 2017. Overview of LAG-3-Expressing, IL-10-Producing Regulatory T Cells. Curr Top Microbiol Immunol 410: 29–45. [DOI] [PubMed] [Google Scholar]
  • 54.Dias S, D’Amico A, Cretney E, Liao Y, Tellier J, Bruggeman C, Almeida FF, Leahy J, Belz GT, Smyth GK, Shi W, and Nutt SL. 2017. Effector Regulatory T Cell Differentiation and Immune Homeostasis Depend on the Transcription Factor Myb. Immunity 46: 78–91. [DOI] [PubMed] [Google Scholar]
  • 55.Mijnheer G, Lutter L, Mokry M, van der Wal M, Scholman R, Fleskens V, Pandit A, Tao W, Wekking M, Vervoort S, Roberts C, Petrelli A, Peeters JGC, Knijff M, de Roock S, Vastert S, Taams LS, van Loosdregt J, and van Wijk F. 2021. Conserved human effector Treg cell transcriptomic and epigenetic signature in arthritic joint inflammation. Nat Commun 12: 2710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Sakaguchi S, Miyara M, Costantino CM, and Hafler DA. 2010. FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol 10: 490–500. [DOI] [PubMed] [Google Scholar]
  • 57.Tai X, Van Laethem F, Pobezinsky L, Guinter T, Sharrow SO, Adams A, Granger L, Kruhlak M, Lindsten T, Thompson CB, Feigenbaum L, and Singer A. 2012. Basis of CTLA-4 function in regulatory and conventional CD4(+) T cells. Blood 119: 5155–5163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Strauss L, Bergmann C, Szczepanski MJ, Lang S, Kirkwood JM, and Whiteside TL. 2008. Expression of ICOS on human melanoma-infiltrating CD4+CD25highFoxp3+ T regulatory cells: implications and impact on tumor-mediated immune suppression. J Immunol 180: 2967–2980. [DOI] [PubMed] [Google Scholar]
  • 59.Li DY, and Xiong XZ. 2020. ICOS(+) Tregs: A Functional Subset of Tregs in Immune Diseases. Front Immunol 11: 2104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Gellatly KJ, Strassner JP, Essien K, Refat MA, Murphy RL, Coffin-Schmitt A, Pandya AG, Tovar-Garza A, Frisoli ML, Fan X, Ding X, Kim EE, Abbas Z, McDonel P, Garber M, and Harris JE. 2021. scRNA-seq of human vitiligo reveals complex networks of subclinical immune activation and a role for CCR5 in T(reg) function. Sci Transl Med 13: eabd8995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Sabat R, Grutz G, Warszawska K, Kirsch S, Witte E, Wolk K, and Geginat J. 2010. Biology of interleukin-10. Cytokine Growth Factor Rev 21: 331–344. [DOI] [PubMed] [Google Scholar]
  • 62.Kim HJ, Barnitz RA, Kreslavsky T, Brown FD, Moffett H, Lemieux ME, Kaygusuz Y, Meissner T, Holderried TA, Chan S, Kastner P, Haining WN, and Cantor H. 2015. Stable inhibitory activity of regulatory T cells requires the transcription factor Helios. Science 350: 334–339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Lam AJ, Uday P, Gillies JK, and Levings MK. 2022. Helios is a marker, not a driver, of human Treg stability. Eur J Immunol 52: 75–84. [DOI] [PubMed] [Google Scholar]
  • 64.Zhan Y, Wang N, Vasanthakumar A, Zhang Y, Chopin M, Nutt SL, Kallies A, and Lew AM. 2020. CCR2 enhances CD25 expression by FoxP3(+) regulatory T cells and regulates their abundance independently of chemotaxis and CCR2(+) myeloid cells. Cell Mol Immunol 17: 123–132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Smith NL, Wissink E, Wang J, Pinello JF, Davenport MP, Grimson A, and Rudd BD. 2014. Rapid proliferation and differentiation impairs the development of memory CD8+ T cells in early life. J Immunol 193: 177–184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Bousso P 2008. T-cell activation by dendritic cells in the lymph node: lessons from the movies. Nat Rev Immunol 8: 675–684. [DOI] [PubMed] [Google Scholar]
  • 67.Groom JR 2015. Moving to the suburbs: T-cell positioning within lymph nodes during activation and memory. Immunol Cell Biol 93: 330–336. [DOI] [PubMed] [Google Scholar]
  • 68.Hugues S, Fetler L, Bonifaz L, Helft J, Amblard F, and Amigorena S. 2004. Distinct T cell dynamics in lymph nodes during the induction of tolerance and immunity. Nat Immunol 5: 1235–1242. [DOI] [PubMed] [Google Scholar]
  • 69.Scheinecker C, McHugh R, Shevach EM, and Germain RN. 2002. Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node. J Exp Med 196: 1079–1090. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Samy ET, Parker LA, Sharp CP, and Tung KS. 2005. Continuous control of autoimmune disease by antigen-dependent polyclonal CD4+CD25+ regulatory T cells in the regional lymph node. J Exp Med 202: 771–781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Hawrylowicz CM, and O’Garra A. 2005. Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma. Nat Rev Immunol 5: 271–283. [DOI] [PubMed] [Google Scholar]
  • 72.De Bruyn Carlier T, Badloe FMS, Ring J, Gutermuth J, and Kortekaas Krohn I. 2021. Autoreactive T cells and their role in atopic dermatitis. J Autoimmun 120: 102634. [DOI] [PubMed] [Google Scholar]
  • 73.Pugliese A 2017. Autoreactive T cells in type 1 diabetes. J Clin Invest 127: 2881–2891. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Gebhardt T, Palendira U, Tscharke DC, and Bedoui S. 2018. Tissue-resident memory T cells in tissue homeostasis, persistent infection, and cancer surveillance. Immunol Rev 283: 54–76. [DOI] [PubMed] [Google Scholar]
  • 75.Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, Kelly TE, Saulsbury FT, Chance PF, and Ochs HD. 2001. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27: 20–21. [DOI] [PubMed] [Google Scholar]
  • 76.Hutloff A, Dittrich AM, Beier KC, Eljaschewitsch B, Kraft R, Anagnostopoulos I, and Kroczek RA. 1999. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature 397: 263–266. [DOI] [PubMed] [Google Scholar]
  • 77.Chen Q, Mo L, Cai X, Wei L, Xie Z, Li H, Li J, and Hu Z. 2018. ICOS signal facilitates Foxp3 transcription to favor suppressive function of regulatory T cells. Int J Med Sci 15: 666–673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Murter B, and Kane LP. 2020. Control of T lymphocyte fate decisions by PI3K signaling. F1000Res 9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Koizumi SI, Sasaki D, Hsieh TH, Taira N, Arakaki N, Yamasaki S, Wang K, Sarkar S, Shirahata H, Miyagi M, and Ishikawa H. 2018. JunB regulates homeostasis and suppressive functions of effector regulatory T cells. Nat Commun 9: 5344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Kornete M, Sgouroudis E, and Piccirillo CA. 2012. ICOS-dependent homeostasis and function of Foxp3+ regulatory T cells in islets of nonobese diabetic mice. J Immunol 188: 1064–1074. [DOI] [PubMed] [Google Scholar]
  • 81.Ritvo PG, Churlaud G, Quiniou V, Florez L, Brimaud F, Fourcade G, Mariotti-Ferrandiz E, and Klatzmann D. 2017. T(fr) cells lack IL-2Ralpha but express decoy IL-1R2 and IL-1Ra and suppress the IL-1-dependent activation of T(fh) cells. Sci Immunol 2. [DOI] [PubMed] [Google Scholar]
  • 82.Habibagahi M, Habibagahi Z, Jaberipour M, and Aghdashi A. 2011. Quantification of regulatory T cells in peripheral blood of patients with systemic lupus erythematosus. Rheumatol Int 31: 1219–1225. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1

Data Availability Statement

Population RNA sequencing data has been uploaded to GEO (GSE262622). Available at https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE262622

RESOURCES